Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemotherapy: Cancer Oesophagus Gefitinib (COG)

類似資料

• Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
  著者:: Dutton, S, 等
  出版事項: (2014)
• Gefitinib and Epidermal Growth Factor Receptor Gene Copy Number Aberrations in Esophageal Cancer
  著者:: Petty, R, 等
  出版事項: (2017)
• Gefitinib and EGFR gene copy number aberrations in esophageal cancer
  著者:: Petty, RD, 等
  出版事項: (2017)
• Busting the Breast Cancer with AstraZeneca’s Gefitinib
  著者:: S. Chemmalar, 等
  出版事項: (2023-01-01)
• Glycyrol Alone or in Combination with Gefitinib Is Effective against Gefitinib-Resistant HCC827GR Lung Cancer Cells
  著者:: Shuang Zhao, 等
  出版事項: (2021-11-01)